Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3796912 | 0.92 | ALDH1A1 (0.39) | ALDH1A1LMNASMN1; SMN2CES2GSK3B | |
| SCHEMBL3802085 | 0.86 | HSD17B10 (0.34) | ALDH1A1LMNASMN1; SMN2ELANEMMP2 | |
| SCHEMBL3801876 | 0.85 | ELANE (0.33) | ALDH1A1LMNASMN1; SMN2ELANEMMP2 | |
| SCHEMBL3022022 | 0.85 | ALDH1A1 (0.40) | ALDH1A1LMNASMN1; SMN2CES2SIGMAR1 | |
| SCHEMBL3797935 | 0.83 | ALDH1A1 (0.38) | ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL3797577 | 0.83 | XDH (0.33) | ALDH1A1LMNASMN1; SMN2ELANEMMP2 | |
| SCHEMBL3792828 | 0.82 | ELANE (0.33) | ALDH1A1LMNASMN1; SMN2ELANEMMP2 | |
| SCHEMBL3803365 | 0.81 | DPP4 (0.38) | ELANEACHETSHR | |
| SCHEMBL3796891 | 0.79 | ALDH1A1 (0.40) | ALDH1A1LMNASMN1; SMN2CES2SIGMAR1 | |
| SCHEMBL3022115 | 0.79 | GSK3B (0.47) | ALDH1A1CES2SIGMAR1GSK3BMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | BASF SE (DE) | 2010-07-08 | — | — | US | claimed |
| EP-2054394-B1 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2009-11-18 | — | — | EP | claimed |
| EP-2054394-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | Basf Se (DE) | 2009-05-06 | — | — | EP | claimed |
| WO-2008152072-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2008-12-18 | — | — | WO | claimed |
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | BASF SE (DE) | 2010-07-08 | — | — | US | disclosed |
| EP-2054394-B1 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-2054394-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | Basf Se (DE) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008152072-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | CBR3, CBR1, CNPY2 | ALDH1A1 1174/4885LMNA 1108/4885SMN1; SMN2 3958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.